Results 181 to 190 of about 471,297 (330)

Endoscopic retrograde cholangiopancreatography for diagnosing and treating pediatric biliary and pancreatic diseases. [PDF]

World J Gastrointest Surg, 2023
Qin XM, Yu FH, Lv CK, Liu ZM, Wu J.
europepmc   +1 more source

Positive Feedback Loop of Histone Lactylation‐Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance

Advanced Science, EarlyView.
Histone 3 lysine18 lactylation (H3K18la) drives heterogeneous nuclear ribonucleoprotein C (HNRNPC) overexpression, activating autophagy to mediate gemcitabine resistance by stabilizing TNF receptor‐associated factor 6 (TRAF6) mRNA. Concurrently, HNRNPC stabilizes aldehyde dehydrogenase 1 family member A3 (ALDH1A3) mRNA, which enhances glycolysis and ...
Xi‐Tai Huang, Jiao Chen, En‐Liang Zhu, Ming‐Jian Ma, Yang‐Yin‐Hui Yu, Ying‐Qin Zhu, Jing‐Yuan Ye, Jin‐Zhao Xie, Zi‐Yi Zhao, Xiao‐Yu Yin   +9 more
wiley   +1 more source

Editorial: Nutrition in pancreatic diseases: the role of nutritional status and nutrition therapy in the management of pancreatitis and pancreatic cancer. [PDF]

Front Nutr
Wiese ML, Perra T, Porcu A.
europepmc   +1 more source

Editorial: Innovative technologies and materials for treatments of hepatobiliary and pancreatic diseases. [PDF]

Front Bioeng Biotechnol, 2023
Li D, Zhao C, Xu W, Liu Y.
europepmc   +1 more source

Targeting NRP1 in Endothelial Cells Facilitates the Normalization of Scar Vessels and Prevents Fibrotic Scarring

Advanced Science, EarlyView.
Scars exhibit vascular abnormal alterations, including upregulated NRP1 expression in endothelial cells, increased vascular density and branching, compromised vessel wall integrity, and incomplete pericyte coverage. Therapeutic targeting of NRP1 through hydrogel spray delivery offers a promising approach to normalize aberrant vasculature and prevent ...
Yu Wang, Xin Zhou, Min Liu, Meimei Huang, Peirong Chen, Xinying Li, Fangchao Xue, Wenyan Zhao, Di Liu, Lang Li, Yuangang Lu, Wen Zeng   +11 more
wiley   +1 more source

PANCREATIC DISEASE [PDF]

Gut, 2001
openaire   +2 more sources

Risk of Pancreatic Cancer in Inflammatory Pancreatic Diseases. [PDF]

Korean J Gastroenterol
Löhr JM, Vujasinovic M, Maisonneuve P.
europepmc   +1 more source

PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites

Advanced Science, EarlyView.
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang, Qian Shen, Yao Lin, Jing Zhu, Xiaolan Zhu, Rui Huang, Yijia Wu, Feiyang Shen, Qian Li, Guopei Zheng, Zhe Zhang, Qian Chu, Junhao Hu, Jianfeng Shen   +13 more
wiley   +1 more source

Implications of gut microbiota in hepatic and pancreatic diseases: Gut-liver-pancreas axis. [PDF]

World J Hepatol
Abdelwahab MM, Ghattas AS, Tawheed A.
europepmc   +1 more source

Nutritional Support in Pancreatic Diseases. [PDF]

Nutrients, 2022
Cañamares-Orbís P, García-Rayado G, Alfaro-Almajano E.   +2 more
europepmc   +1 more source